S. Ropert
发表
O. Mir,
E. Raymond,
F. Goldwasser,
2016,
International journal of nanomedicine.
Reversible Decrease of Portal Venous Flow in Cirrhotic Patients: A Positive Side Effect of Sorafenib
O. Mir,
H. Gouya,
O. Vignaux,
2011,
PloS one.
O. Mir,
F. Goldwasser,
R. Coriat,
2012,
Investigational New Drugs.
O. Mir,
F. Goldwasser,
R. Coriat,
2011,
Pharmaceutical Research.
J. Soria,
C. Robert,
J. Armand,
2010,
Cancer Chemotherapy and Pharmacology.
W. Cacheux,
O. Mir,
F. Goldwasser,
2012,
Investigational New Drugs.
P. Fournel,
F. Guisier,
C. Chouaid,
2020,
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
O. Mir,
A. Paci,
S. Ropert,
2018,
Annals of oncology : official journal of the European Society for Medical Oncology.
F. Goldwasser,
P. Tran,
R. Coriat,
2018
.
R. Gaillard,
O. Mir,
S. Dauchy,
2018,
Investigational New Drugs.
O. Mir,
F. Goldwasser,
S. Pol,
2012,
Medical Oncology.
O. Mir,
F. Goldwasser,
R. Coriat,
2012,
Investigational New Drugs.
F. Goldwasser,
S. Ropert,
B. Billemont,
2014,
BMC Cancer.
O. Mir,
F. Goldwasser,
R. Coriat,
2012,
Investigational New Drugs.
J. Baselga,
J. Soria,
J. Cortes,
2019,
Annals of oncology : official journal of the European Society for Medical Oncology.
O. Mir,
F. Goldwasser,
S. Pol,
2012,
PloS one.
O. Mir,
F. Goldwasser,
R. Coriat,
2012,
The oncologist.
O. Mir,
F. Goldwasser,
R. Coriat,
2011,
Inflammatory bowel diseases.
F. Goldwasser,
S. Ropert,
J. Alexandre,
2009,
Annals of oncology : official journal of the European Society for Medical Oncology.
F. Goldwasser,
V. Diéras,
S. Grabar,
2011,
British Journal of Cancer.
S. Ropert,
Marion Durand,
V. Zarka,
2019,
Journal of thoracic disease.
O. Mir,
L. Faivre,
F. Goldwasser,
2011,
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
O. Mir,
F. Goldwasser,
B. Knebelmann,
2012,
Investigational New Drugs.
O. Mir,
F. Goldwasser,
F. Goffinet,
2008,
Annals of oncology : official journal of the European Society for Medical Oncology.
S. Laurent,
P. Boutouyrie,
M. Briet,
2013
.
O. Mir,
F. Goldwasser,
O. Launay,
2008,
Annals of oncology : official journal of the European Society for Medical Oncology.
O. Mir,
O. Vignaux,
F. Goldwasser,
2011,
Investigational New Drugs.
E. Fadel,
A. Cesne,
O. Mir,
2022,
Cancer medicine.
S. Ropert,
F. Goldwasser,
O. Mir,
2010
.
O. Mir,
F. Goldwasser,
R. Coriat,
2010
.
O. Mir,
F. Goldwasser,
M. Leconte,
2010,
Cancer Chemotherapy and Pharmacology.
O. Mir,
M. Toulmonde,
R. Coriat,
2016,
Acta oncologica.
O. Mir,
F. Scotté,
P. Loulergue,
2020,
Annals of oncology : official journal of the European Society for Medical Oncology.
O. Mir,
F. Goldwasser,
J. Treluyer,
2007,
The Lancet. Oncology.
O. Mir,
F. Goldwasser,
S. Ropert,
2008,
Annals of Oncology.
O. Mir,
F. Goldwasser,
F. Goffinet,
2008,
Cancer.
F. Goldwasser,
M. Avril,
S. Barete,
2010,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
F. Goldwasser,
M. Tod,
S. Ropert,
2009,
Clinica chimica acta; international journal of clinical chemistry.
O. Mir,
F. Goldwasser,
C. Nicco,
2012,
Molecular Cancer Therapeutics.
J. Soria,
B. Besse,
S. Ropert,
2007,
Annals of oncology : official journal of the European Society for Medical Oncology.
O. Mir,
F. Goldwasser,
C. Tlemsani,
2011,
Targeted Oncology.
F. Bonnetain,
E. Barret,
D. Prapotnich,
2018,
BJU international.
O. Mir,
L. Faivre,
F. Goldwasser,
2011,
Investigational New Drugs.
F. Goldwasser,
Y. Loriot,
S. Ropert,
2008,
Annals of oncology : official journal of the European Society for Medical Oncology.
O. Mir,
P. Morice,
S. Ropert,
2019,
Mayo Clinic proceedings.
P. Terrier,
A. Cesne,
O. Mir,
2016
.
O. Mir,
F. Goldwasser,
R. Coriat,
2012,
Anti-cancer drugs.
O. Mir,
F. Goldwasser,
S. Ropert,
2009,
Anti-cancer drugs.
F. Goldwasser,
S. Ropert,
J. Alexandre,
2006,
Annals of oncology : official journal of the European Society for Medical Oncology.
O. Mir,
F. Goldwasser,
P. Beuzeboc,
2005,
Anti-cancer drugs.
O. Mir,
M. Peyromaure,
F. Goldwasser,
2013,
British Journal of Cancer.
O. Mir,
P. Burgel,
F. Goldwasser,
2012,
Lung cancer.
Bertrand Knebelmann,
Jean-Marc Treluyer,
O. Mir,
2011,
The oncologist.
F. Goldwasser,
J. Cramard,
S. Chhun,
2009,
Journal of pharmaceutical and biomedical analysis.
M. Poupon,
F. Assayag,
F. Sennlaub,
2008,
Proceedings of the National Academy of Sciences.
O. Mir,
F. Goldwasser,
R. Coriat,
2011,
Investigational New Drugs.
B. Lévy,
M. Pocard,
C. Eveno,
2011,
The American journal of pathology.
E. Barret,
D. Prapotnich,
X. Cathelineau,
2013,
Expert review of anticancer therapy.
N. Magné,
B. Chauffert,
F. Ducray,
2020,
European Journal of Cancer.
O. Mir,
O. Vignaux,
F. Goldwasser,
2011,
Investigational New Drugs.
R. Gaillard,
O. Mir,
F. Goldwasser,
2012,
Supportive Care in Cancer.
O. Mir,
F. Goldwasser,
S. Ropert,
2008,
The Lancet. Oncology.
R. Dhôte,
S. Ropert,
B. Christoforov,
2003,
Gut.
Cost effectiveness of integrated medicine in patients with cancer receiving anticancer chemotherapy.
O. Mir,
F. Goldwasser,
R. Coriat,
2012,
Journal of oncology practice.
O. Mir,
F. Goldwasser,
R. Coriat,
2011,
Investigational New Drugs.
J. Baselga,
J. Soria,
J. Cortes,
2019,
Annals of oncology : official journal of the European Society for Medical Oncology.
O. Mir,
F. Goldwasser,
F. Larousserie,
2010,
Cancer Chemotherapy and Pharmacology.
O. Mir,
F. Goldwasser,
S. Ropert,
2009,
The Lancet Oncology.
O. Mir,
A. Paci,
J. Armand,
2017,
European Journal of Cancer.
O. Mir,
F. Goldwasser,
R. Coriat,
2012,
Anti-Cancer Drugs.
O. Mir,
F. Goldwasser,
S. Ropert,
2009,
Anti-cancer drugs.
F. Goldwasser,
J. Cramard,
S. Chhun,
2009,
Journal of pharmaceutical and biomedical analysis.
F. Goldwasser,
P. Beuzeboc,
M. Zerbib,
2012,
Bulletin du cancer.
O. Mir,
F. Goldwasser,
J. Clerc,
2011,
The Lancet.